Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.
Wehling C, Amon O, Bommer M, Hoppe B, Kentouche K, Schalk G, Weimer R, Wiesener M, Hohenstein B, Tönshoff B, Büscher R, Fehrenbach H, Gök ÖN, Kirschfink M.
Wehling C, et al.
Clin Exp Immunol. 2017 Feb;187(2):304-315. doi: 10.1111/cei.12890. Epub 2016 Nov 25.
Clin Exp Immunol. 2017.
PMID: 27784126
Free PMC article.